Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

The software does not perform authentication for functionality that requires a provable user identity.CVE-2018-14786 has been assigned to this vulnerability. A CVSS v3 base score of 9.4 has been calculated; the CVSS vector string is (AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H).